- Home
- XOMAP vs JPC Comparison
XOMAP vs JPC Comparison
Compare XOMAP & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMAP
- JPC
- Stock Information
- Founded
- XOMAP N/A
- JPC 2003
- Country
- XOMAP United States
- JPC United States
- Employees
- XOMAP 13
- JPC N/A
- Industry
- XOMAP Biotechnology: Pharmaceutical Preparations
- JPC Investment Managers
- Sector
- XOMAP Health Care
- JPC Finance
- Exchange
- XOMAP Nasdaq
- JPC Nasdaq
- Market Cap
- XOMAP N/A
- JPC N/A
- IPO Year
- XOMAP N/A
- JPC N/A
- Fundamental
- Price
- XOMAP $25.95
- JPC $7.36
- Analyst Decision
- XOMAP
- JPC
- Analyst Count
- XOMAP 0
- JPC 0
- Target Price
- XOMAP N/A
- JPC N/A
- AVG Volume (30 Days)
- XOMAP N/A
- JPC 998.5K
- Earning Date
- XOMAP N/A
- JPC 01-01-0001
- Dividend Yield
- XOMAP N/A
- JPC 7.57%
- EPS Growth
- XOMAP N/A
- JPC N/A
- EPS
- XOMAP N/A
- JPC N/A
- Revenue
- XOMAP N/A
- JPC N/A
- Revenue This Year
- XOMAP N/A
- JPC N/A
- Revenue Next Year
- XOMAP N/A
- JPC N/A
- P/E Ratio
- XOMAP N/A
- JPC N/A
- Revenue Growth
- XOMAP N/A
- JPC N/A
- 52 Week Low
- XOMAP N/A
- JPC $5.94
- 52 Week High
- XOMAP N/A
- JPC $7.36
- Technical
- Relative Strength Index (RSI)
- XOMAP 52.85
- JPC 41.59
- Support Level
- XOMAP $24.96
- JPC $7.07
- Resistance Level
- XOMAP $26.10
- JPC $7.48
- Average True Range (ATR)
- XOMAP 0.38
- JPC 0.22
- MACD
- XOMAP 0.03
- JPC -0.01
- Stochastic Oscillator
- XOMAP 76.74
- JPC 48.31
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.